Arbor Biotechnologies
David Cheng is the Chief Technology Officer at Arbor Biotechnologies. He was formerly an Executive Director at JPMorgan.
David earned his Master of Engineering degree in Computer Science from the Massachusetts Institute of Technology.
Arbor Biotechnologies
2 followers
Arbor Biotechnologies is an early stage life sciences company pushing the boundaries of biodiscovery. Arbor’s platform employs a diverse set of technologies and techniques – including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening – for accelerating the discovery of proteins for improving human health and sustainability.